Kuhn Kristine A, Pedraza Isabel, Demoruelle M Kristen
Division of Rheumatology, University of Colorado School of Medicine, 13001 E. 17th Place, Aurora, CO 80045, USA.
Division of Pulmonary/Critical Care Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.
Rheum Dis Clin North Am. 2014 Nov;40(4):711-25. doi: 10.1016/j.rdc.2014.07.013. Epub 2014 Sep 4.
The etiology of most systemic autoimmune diseases remains unknown. There is often a preclinical period of systemic autoimmunity prior to the onset of clinically classifiable disease; established and emerging data suggest that dysregulated immune interactions with commensal microbiota may play a role in the initial generation of autoimmunity in this preclinical period. This article reviews potential mechanisms by which alterations of healthy microbiota may induce autoimmunity as well as mucosal microbial associations with autoimmune diseases. If mucosal microbiota lead to the development of autoimmunity, these mucosal sites, microorganisms, and immunologic mechanisms can be targeted to prevent the onset of systemic autoimmune disease.
大多数系统性自身免疫性疾病的病因仍不清楚。在临床上可分类疾病发作之前,通常存在一个系统性自身免疫的临床前期;已有的和新出现的数据表明,与共生微生物群失调的免疫相互作用可能在这个临床前期自身免疫的初始产生中起作用。本文综述了健康微生物群改变可能诱发自身免疫的潜在机制,以及黏膜微生物与自身免疫性疾病的关联。如果黏膜微生物群导致自身免疫的发生,那么这些黏膜部位、微生物和免疫机制可以作为靶点,以预防系统性自身免疫性疾病的发作。